Pfizer post-pandemic financial performance and strategic pivot
The developments in this story so far, most recent first.
-
· date approximate Development
Pfizer exceeds second-quarter estimates, raises revenue outlook
-
· date approximate Background
Pfizer's 2025 annual revenue reached $62.6 billion.
Pfizer recorded an annual revenue of $62.6 billion for the year 2025.
-
Date unknown Background
Pfizer completed a $10 billion acquisition of obesity biotech Metsera.
No separate article for this desk or language yet.